
Due to an unexpected increase in serious cardiovascular events in zzso patients treated with zzso a synthetic zzso two zzso multinational zzso zzso zzso and secondary progressive zzso zzso trials had to be zzso zzso results of 413 patients who participated for at least 3 months were zzso Patients received zzso zzso or 5 zzso zzso zzso were performed at zzso month 3 and zzso The number and volume of enhancing zzso zzso and the number of active scans were zzso At month 3, the decrease in the number of enhancing zzso in the zzso group was zzso compared with zzso in the zzso zzso group zzso and zzso in the 5 zzso group zzso Using the percentage of active scans as outcome zzso the odds ratio for improvement between zzso and zzso zzso group was zzso zzso between zzso and 5 zzso zzso group zzso zzso At zzso a rebound effect was noted in the zzso zzso group zzso Analysis of the zzso showed no significant difference between zzso and treatment zzso Although zzso has unacceptable side effects, it seems to have a modest effect on zzso disease activity, as measured by zzso Multiple zzso zzso 6, 99 - 104 

